Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 25% ± 2% | |
transit amplifying cell | 3 studies | 41% ± 17% |
Insufficient scRNA-seq data for expression of NCAPG2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 763.60 | 1444 / 1445 | 99% | 21.83 | 182 / 183 |
uterus | 100% | 637.54 | 170 / 170 | 98% | 27.25 | 452 / 459 |
breast | 100% | 755.54 | 459 / 459 | 98% | 19.56 | 1097 / 1118 |
intestine | 100% | 698.65 | 963 / 966 | 98% | 19.97 | 517 / 527 |
skin | 100% | 2001.42 | 1807 / 1809 | 97% | 23.54 | 459 / 472 |
stomach | 99% | 581.94 | 356 / 359 | 97% | 18.56 | 277 / 286 |
lung | 99% | 634.12 | 573 / 578 | 96% | 18.06 | 1114 / 1155 |
brain | 98% | 444.05 | 2593 / 2642 | 97% | 13.56 | 685 / 705 |
bladder | 100% | 502.29 | 21 / 21 | 95% | 18.32 | 480 / 504 |
ovary | 100% | 533.76 | 180 / 180 | 94% | 12.70 | 406 / 430 |
prostate | 100% | 478.41 | 244 / 245 | 79% | 6.26 | 399 / 502 |
pancreas | 87% | 249.74 | 285 / 328 | 89% | 8.86 | 159 / 178 |
thymus | 100% | 527.63 | 651 / 653 | 73% | 6.92 | 441 / 605 |
kidney | 100% | 418.63 | 89 / 89 | 67% | 5.46 | 608 / 901 |
adrenal gland | 97% | 479.26 | 250 / 258 | 68% | 6.86 | 156 / 230 |
liver | 82% | 244.04 | 186 / 226 | 52% | 4.84 | 213 / 406 |
adipose | 100% | 718.97 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 975.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.61 | 45 / 45 |
blood vessel | 99% | 505.28 | 1327 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 361.70 | 788 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 18.97 | 27 / 29 |
heart | 88% | 324.30 | 758 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 1547.93 | 711 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 3.97 | 47 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1905820 | Biological process | positive regulation of chromosome separation |
GO_0001833 | Biological process | inner cell mass cell proliferation |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_1905821 | Biological process | positive regulation of chromosome condensation |
GO_0051301 | Biological process | cell division |
GO_0051984 | Biological process | positive regulation of chromosome segregation |
GO_0000070 | Biological process | mitotic sister chromatid segregation |
GO_0030261 | Biological process | chromosome condensation |
GO_0016607 | Cellular component | nuclear speck |
GO_0000796 | Cellular component | condensin complex |
GO_0000794 | Cellular component | condensed nuclear chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0043425 | Molecular function | bHLH transcription factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NCAPG2 |
Protein name | Non-SMC condensin II complex subunit G2 Condensin-2 complex subunit G2 (Chromosome-associated protein G2) (CAP-G2) (hCAP-G2) (Leucine zipper protein 5) (Non-SMC condensin II complex subunit G2) |
Synonyms | LUZP5 |
Description | FUNCTION: Regulatory subunit of the condensin-2 complex, a complex which establishes mitotic chromosome architecture and is involved in physical rigidity of the chromatid axis. . |
Accessions | ENST00000441982.5 ENST00000356309.8 [Q86XI2-1] ENST00000432615.5 ENST00000409339.3 [Q86XI2-2] H0Y6U5 Q86XI2 F8WE06 ENST00000409423.5 [Q86XI2-1] |